STOCK TITAN

CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

CryoLife, Inc. (NYSE: CRY) announced the release date for its fourth quarter and full year 2020 financial results, set for February 11, 2021, after market closure. A teleconference call will follow at 4:30 p.m. ET, led by Pat Mackin, Chairman and CEO. Investors can participate by calling 201-689-8261. Replay will be available from February 11 to 18, 2021. The financial results will be accessible on the CryoLife website in the Investor Relations section.

Positive
  • None.
Negative
  • None.

ATLANTA, Jan. 28, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2020 financial results will be released on Thursday, February 11, 2021 after the market closes.  On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of CryoLife, Inc.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET.  A replay of the teleconference will be available February 11 through February 18, 2021 and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415.  The conference number for the replay is 13715710.

The live webcast and replay can be accessed in the Investor Relations section of the CryoLife website at www.cryolife.com and selecting Webcasts & Presentations.  In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investor Relations section of the CryoLife website.

About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.  CryoLife markets and sells products in more than 100 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:

CryoLife       

D. Ashley Lee                                                

Executive Vice President, Chief Financial Officer   
 and Chief Operating Officer 
Phone: 770-419-3355

Gilmartin Group LLC

Brian Johnston / Lynn Lewis

Phone:  631-807-1986

investors@cryolife.com

 

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-announces-release-date-and-teleconference-call-details-for-fourth-quarter-and-full-year-2020-financial-results-301217105.html

SOURCE CryoLife, Inc.

FAQ

When will CryoLife release its fourth quarter and full year 2020 financial results?

CryoLife will release its financial results on February 11, 2021, after market closure.

What time is the teleconference call regarding CryoLife's financial results?

The teleconference call is scheduled for 4:30 p.m. ET on February 11, 2021.

How can I access the replay of CryoLife's teleconference?

The replay will be available from February 11 to 18, 2021, by calling 877-660-6853 or 201-612-7415.

Where can I find CryoLife's financial results and information?

Financial results will be available in the Investor Relations section of the CryoLife website.

CRY

NYSE:CRY

CRY Rankings

CRY Latest News

CRY Stock Data

37.72M
11.11%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Kennesaw